TBX18 antisense RNA 1 (TBX18-AS1)

TBX18 antisense RNA 1 (TBX18-AS1) is predicted to be a long non-coding RNA transcribed antisense to the TBX18 gene, a member of the T-box transcription factor family[4]. There is currently no published data on its biological activity, disease relevance, or druggability. It is not recognized as a therapeutic target and is primarily referenced as a putative gene in genome annotations. All known disease roles and functional studies refer to the TBX18 protein, not TBX18-AS1[4]. The lack of structured, peer-reviewed information and absence in major gene browsers or databases confirms that TBX18-AS1 is not a validated target. If you intended to ask about TBX18 (T-box transcription factor 18), substantial information on its function, disease associations, and molecular biology is available[1][2][4]. TBX18-AS1 is not currently considered a therapeutic target. It may be incorrectly named, missing information, or simply uncharacterized in the current literature—hence, "is_incorrect" is true. There are no drugs, mechanisms of action, biomarkers, or safety concerns described for this molecule. All available data pertains to TBX18 (the transcription factor), not TBX18-AS1 (the antisense RNA)[4].

Other names

TBX18-AS1